The JAK1/JAK2-inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Scopus)
24 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1412-1420
Number of pages9
JournalClinical & Experimental Allergy
Volume48
Issue number11
DOIs
Publication statusPublished - 2018

Research programs

  • EMC MM-02-72-02
  • EMC OR-01-39-07

Cite this